Stock News Biopharma companies Evommune and Nektar soar on eczema treatment data Investors were highly intrigued by their successful studies Rowan DunneFebruary 11, 2026
Medical and Pharmaceutical Corvus rally continues as clinical optimism offsets dilution concerns Corvus strengthened its balance sheet by pricing an upsized public offering Joseph MortonJanuary 23, 2026
The weed wire CBD substantially reduces eczema in dogs: company study Australian animal health company CannPall is using the results to commercialize their product and apply for a patent Nick LabaJuly 21, 2020